Session 6: Covid-19 Vaccine Demand Planning and Product Choices
This live session offered Boost Members, Ministries of Health and NITAGs practical tools, considerations and recommendations in their COVID-19 vaccine product choices to optimize their portfolio.
Despite significant improvements to access to COVID-19 vaccine products, countries may not be able to access all required doses through a single product. COVID-19 vaccines available have different characteristics. Intentional planning of the portfolio of COVID-19 vaccine products is essential to the success of a country’s achievement of time-bound targets and goals.
Panelists
Dr. Alba Vilajeliu
Dr. Ampeire Immaculate
Jimmy Ameny
Benjamin Schreiber
This session spotlighted WHO technical leadership to support countries when making a choice of COVID-19 vaccine products and the size of the portfolio of the various products according to their comparative advantage for different uses. The session will also featured an overview of the updated monthly COVAX allocation process, which is demand-driven and builds on a country’s choices of coverage targets, priority populations, and COVID-19 vaccine products to meet those targets. Finally, the session highlighted Uganda’s experience navigating product choices and demand forecasting as they developed their product portfolio for the next 6 months.